We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Patterson-UTI
PTEN
$3.87B
| $8.59M | 0.14% |
+271,250
| New | +$7.54M |
|
|
BERY
202
DELISTED
Berry Global Group, Inc.
BERY
| $8.47M | 0.14% |
398,302
-31,036
| -7% | -$664K |
|
|
ORB
203
DELISTED
ORBITAL SCIENCES CORP
ORB
| $8.4M | 0.14% |
301,051
-4,070
| -1% | -$107K |
|
|
PETM
204
DELISTED
PETSMART INC
PETM
| $8.39M | 0.14% |
121,764
-75,940
| -38% | -$5.03M |
|
205
Charter Communications
CHTR
$14.7B
| $8.34M | 0.14% |
+67,690
| New | +$8.86M |
|
206
TD Synnex
SNX
$19.4B
| $8.26M | 0.14% |
272,666
+96,820
| +55% | +$2.88M |
|
207
Westlake Corp
WLK
$9.46B
| $8.25M | 0.14% |
124,712
+120,176
| +2,649% | +$7.64M |
|
208
ABM Industries
ABM
$2.8B
| $8.13M | 0.14% |
282,843
-5,610
| -2% | -$156K |
|
209
SPX Corp
SPXC
$11B
| $8.03M | 0.13% |
+324,272
| New | +$8.31M |
|
|
ULTI
210
DELISTED
Ultimate Software Group Inc
ULTI
| $7.93M | 0.13% |
57,868
+47,689
| +469% | +$7.48M |
|
211
DexCom
DXCM
$27.6B
| $7.69M | 0.13% |
744,100
+510,564
| +219% | +$5.28M |
|
|
ITG
212
DELISTED
Investment Technology Group Inc
ITG
| $7.64M | 0.13% |
378,135
+33,100
| +10% | +$597K |
|
213
Caleres
CAL
$396M
| $7.62M | 0.13% |
287,070
-2,400
| -0.8% | -$60.3K |
|
|
TCO
214
DELISTED
Taubman Centers Inc.
TCO
| $7.57M | 0.13% |
106,932
-47,201
| -31% | -$3.2M |
|
215
Huntsman Corp
HUN
$2.24B
| $7.34M | 0.12% |
300,760
+94,030
| +45% | +$2.18M |
|
|
ARUN
216
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $7.29M | 0.12% |
388,950
-246,468
| -39% | -$4.93M |
|
217
Pfizer
PFE
$140B
| $7.27M | 0.12% |
238,620
-1,149,061
| -83% | -$34.3M |
|
218
Green Dot
GDOT
$753M
| $7.26M | 0.12% |
371,517
+34,169
| +10% | +$756K |
|
|
ARRS
219
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $7.2M | 0.12% |
255,394
-1,199,594
| -82% | -$32.7M |
|
220
Corpay
CPAY
$24.2B
| $7.18M | 0.12% |
62,402
+59,206
| +1,853% | +$6.89M |
|
221
Commault Systems
CVLT
$5.89B
| $7.13M | 0.12% |
109,820
-3,040
| -3% | -$210K |
|
222
Norwegian Cruise Line
NCLH
$8.89B
| $7.03M | 0.12% |
217,846
-216,900
| -50% | -$7.41M |
|
|
CVC
223
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $6.94M | 0.12% |
411,400
+6,325
| +2% | +$106K |
|
224
Forward Air
FWRD
$482M
| $6.85M | 0.11% |
+148,651
| New | +$6.57M |
|
|
SHOR
225
DELISTED
ShoreTel, Inc.
SHOR
| $6.81M | 0.11% |
792,348
-48,900
| -6% | -$422K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.